Noel J-M Raynal

Noel J-M Raynal

UNVERIFIED PROFILE

Are you Noel J-M Raynal?   Register this Author

Register author
Noel J-M Raynal

Noel J-M Raynal

Publications by authors named "Noel J-M Raynal"

Are you Noel J-M Raynal?   Register this Author

16Publications

503Reads

42Profile Views

DNA Methylation-Targeted Drugs.

Cancer J 2017 Sep/Oct;23(5):270-276

From the Département de Pharmacologie et de Physiologie, Université de Montréal and Sainte-Justine University Hospital Research Center, Montréal, Québec, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0000000000000278DOI Listing
May 2018

Repositioning FDA-Approved Drugs in Combination with Epigenetic Drugs to Reprogram Colon Cancer Epigenome.

Mol Cancer Ther 2017 02 15;16(2):397-407. Epub 2016 Dec 15.

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-16-0588DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292054PMC
February 2017

Hypomethylation of TET2 Target Genes Identifies a Curable Subset of Acute Myeloid Leukemia.

J Natl Cancer Inst 2015 Nov 13;108(2). Epub 2015 Nov 13.

Fels Institute for Cancer Research and Molecular Biology, Temple University, Philadelphia, PA (JY, JJ, NJMR, MC, JPJI); Department of Leukemia (JY, RT, JJ, NJMR, SAP, SMK, FR, HMK, JPJI) and Department of Hematopathology (CEBR), The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv323DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4862435PMC
November 2015

Epigenetic synergy between decitabine and platinum derivatives.

Clin Epigenetics 2015 11;7:97. Epub 2015 Sep 11.

Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX 77030 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s13148-015-0131-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567801PMC
September 2015

Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees.

EMBO Rep 2011 Mar 18;12(3):238-43. Epub 2011 Feb 18.

Department of Molecular Carcinogenesis, University of Texas MD Anderson Cancer Center, Park Road 1C, Smithville, Texas 78957, USA.

View Article

Download full-text PDF

Source
http://embor.embopress.org/cgi/doi/10.1038/embor.2011.9
Publisher Site
http://dx.doi.org/10.1038/embor.2011.9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3059907PMC
March 2011

3-Deazauridine enhances the antileukemic action of 5-aza-2'-deoxycytidine and targets drug-resistance due to deficiency in deoxycytidine kinase.

Leuk Res 2011 Jan 26;35(1):110-8. Epub 2010 May 26.

Service of Hematology and Oncology, Université de Montréal and Centre de Recherche, CHU-Saint-Justine, 3175 Ste. Catherine Road, Montréal, Québec, H3T 1C5 Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2010.04.014DOI Listing
January 2011

Synergistic effect of 5-Aza-2'-deoxycytidine and genistein in combination against leukemia.

Oncol Res 2008 ;17(5):223-30

INRS-Institut Armand-Frappier, Université du Québec, Laval, Quebec H7V 1B7, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3727/096504008786111356DOI Listing
March 2009

Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.

Cancer Chemother Pharmacol 2009 Feb 9;63(3):411-6. Epub 2008 Apr 9.

Département de Pharmacologie, Université de Montréal, QC, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00280-008-0750-6DOI Listing
February 2009

Antileukemic activity of genistein, a major isoflavone present in soy products.

J Nat Prod 2008 Jan 29;71(1):3-7. Epub 2007 Dec 29.

INRS-Institut Armand-Frappier, Université du Québec, Laval, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1021/np070230sDOI Listing
January 2008